Skip to content 
Africure Pharmaceuticals
In a continent long dependent on imported medicines, Africure Pharmaceuticals Limited is leading a transformative shift—building a sustainable, self-reliant pharmaceutical ecosystem across Sub-Saharan Africa.
Founded in 2017 by Sinhue Bosco Noronha, the company was established with a clear mission: to make quality healthcare affordable and accessible while reducing Africa’s reliance on costly imports. At its core lies a powerful vision—“Made in Africa, by Africans, for Africa”—which drives its strategy of local manufacturing and regional expansion.
Africure’s approach directly addresses some of Africa’s most pressing healthcare challenges, including medicine shortages, high costs, and the circulation of substandard drugs. By building manufacturing facilities in underserved regions, the company is ensuring a steady and reliable supply of essential medicines. Today, it operates plants across countries such as Cameroon, Côte d’Ivoire, Tanzania, Botswana, and Namibia, with further expansion planned in Ethiopia and beyond.
A key differentiator of Africure is its unique “management contract” model. Instead of only building new facilities, the company revitalizes struggling pharmaceutical plants by optimizing operations, sourcing raw materials, and improving production and distribution. This not only boosts profitability but also strengthens local industry capabilities—creating jobs and fostering economic growth.
The company’s commitment to quality is equally strong. Its manufacturing facilities are designed to meet global cGMP (current Good Manufacturing Practice) standards, ensuring that medicines are safe, effective, and consistent. Africure produces a wide range of essential drugs, including antibiotics, antimalarials, antivirals, and treatments for chronic conditions—critical for addressing Africa’s disease burden.
Beyond manufacturing, Africure is building an integrated ecosystem that includes distribution networks across multiple African countries, ensuring medicines reach even remote populations. This end-to-end approach—from production to delivery—helps eliminate supply chain gaps and improves accessibility.
What truly sets Africure apart is its long-term vision of pharmaceutical self-sufficiency. Africa currently imports a significant portion of its medicines, making it vulnerable to global supply disruptions and price fluctuations. Africure aims to change this by creating local capabilities that reduce dependency and empower the continent to meet its own healthcare needs.
The company also emphasizes local workforce development, employing and training talent within the regions it operates. This not only ensures sustainability but also builds technical expertise across the continent—laying the foundation for a robust pharmaceutical industry.
In conclusion, Africure Pharmaceuticals is more than a pharmaceutical company—it is a catalyst for change in Africa’s healthcare landscape. By combining innovation, local manufacturing, and a strong social mission, it is helping transform the continent from a medicine importer into a self-sufficient healthcare powerhouse.
